Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis

Donald E. Stull; Christopher Em Griffiths; I. Gilloteau; Yang Zhao; Adriana Guana; A.Y. Finlay; Bintu Sherif; Katherine Houghton; L. Puig

doi:10.1111/bjd.16366

Shared by

Christopher Em Griffiths

Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis

Article 2018 en

Authors

DS
Donald E. Stull
Christopher Em Griffiths
IG
I. Gilloteau

Abstract

1 min read

The results underscore the important role of both PASI response and reduction in symptoms on improvements in health-related quality of life and work and daily activity in favour of secukinumab vs. ustekinumab.

Discussion(0)

No comments yet. Be the first to comment.

Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis

Abstract

Discussion(0)

Related publications

Secukinumab improves the quality‐of‐life of family members and partners of people with psoriasis: Family Dermatology Life Quality Index (FDLQI) results from a randomised open‐label study (SIGNATURE)

O10 STAT3 activation in peripheral blood MAIT cells is a predictive biomarker of response to biologics targeting the IL-23/IL-17 axis

Do burnout and work engagement predict depressive symptoms and life satisfaction? A three-wave seven-year prospective study

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

Health-Related Quality of Life and Lifestyle Behavior Clusters in School-Aged Children from 12 Countries

Related publications

Article2022
Secukinumab improves the quality‐of‐life of family members and partners of people with psoriasis: Family Dermatology Life Quality Index (FDLQI) results from a randomised open‐label study (SIGNATURE)
Article2022

Article2023
O10 STAT3 activation in peripheral blood MAIT cells is a predictive biomarker of response to biologics targeting the IL-23/IL-17 axis
Article2023

Article2012
Do burnout and work engagement predict depressive symptoms and life satisfaction? A three-wave seven-year prospective study
Article2012

Article1997
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress
Article1997

Article2017
Health-Related Quality of Life and Lifestyle Behavior Clusters in School-Aged Children from 12 Countries
Article2017